Blincyto Drug Interactions: 219 Major, 67 Moderate
Blincyto (Blinatumomab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Blincyto. Always confirm against the full prescribing information.
100 interactions
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Blinatumomab.
Level 1 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Blinatumomab.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Articaine.
Level 1 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Blinatumomab.
Level 2 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Benzyl alcohol.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Blinatumomab.
Level 2 evidence
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Bupivacaine.
Level 1 evidence
Butamben
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Butamben.
Level 1 evidence
Capsaicin
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Capsaicin.
Level 1 evidence
Chloroprocaine
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Chloroprocaine.
Level 1 evidence
Cinchocaine
The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Cinchocaine.
Level 1 evidence
Enter your NPI to unlock 48 major interactions for Blincyto
Blincyto (Blinatumomab) has 460 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Blincyto (Blinatumomab) has 219 major, 67 moderate, and 174 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Blincyto. Always confirm against the full prescribing information.